EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial Activity of Ligilactobacillus animalis SWLA-1 and Its Cell-Free Supernatant against Multidrug-Resistant Bacteria and Its Potential Use as an Alternative to Antimicrobial Agents

Hong-Jae Lee iD, Joong-Bok Lee iD, Seung-Yong Park, In-Soo Choi, Sang-Won Lee

Microorganisms · 11.01.2023 · 11 (1) · 182

DOI: 10.3390/microorganisms11010182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 11.01.2023. Verfasst von Hong-Jae Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Infectious Diseases and Veterinary Microbiology, College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of multidrug-resistant (MDR) bacteria and the spread of antimicrobial resistance among various bacteria are major threats to the global community. Due to the increased failure of classical antibiotic treatments against MDR bacterial infections, probiotics and their antimicrobial compounds have been suggested as promising alternatives to deal with MDR bacteria. Various strains of lactic acid bacteria have been reported to produce antagonistic molecules against pathogens. A new strain of Ligilactobacillus animalis, L. animalis SWLA-1, isolated from the feces of healthy dogs, shows strong antimicrobial activity against not only common pathogens but also MDR bacteria. In this study, we compared the antimicrobial activity of L. animalis SWLA-1 with that of other lactobacilli and antibiotics using an agar spot assay. Additionally, a novel spot inhibition index was developed and validated to quantitively evaluate the inhibitory activities of lactobacilli and antibiotics. A competitive coculture assay of L. animalis SWLA-1 with MDR bacteria further demonstrated its antibacterial activity. Furthermore, we evaluated the antimicrobial activity of the cell-free supernatant (CFS) of L. animalis SWLA-1 and its stability under various conditions in vitro. We found that L. animalis SWLA-1 and its CFS are potential alternatives to classic antimicrobial agents.

Schlagwörter

Stichwörter der Autor:innen

Ligilactobacillus animalisantimicrobial substancescell-free supernatant (CFS)competitive coculture assaymultidrug-resistant (MDR) bacteriaspot agar assayspot inhibition index (SII)

Autor:innen und Institutionen

  • Laboratory of Infectious Diseases and Veterinary Microbiology, College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea.

ORCID-Profile: Hong-Jae Lee, Joong-Bok Lee

Zitieren

APA

Lee, H. J., Lee, J. B., Park, S. Y., Choi, I. S., & Lee, S. W. (2023). Antimicrobial Activity of Ligilactobacillus animalis SWLA-1 and Its Cell-Free Supernatant against Multidrug-Resistant Bacteria and Its Potential Use as an Alternative to Antimicrobial Agents. Microorganisms, 11(1), 182. https://doi.org/10.3390/microorganisms11010182

Vancouver

Lee HJ, Lee JB, Park SY, Choi IS, Lee SW. Antimicrobial Activity of Ligilactobacillus animalis SWLA-1 and Its Cell-Free Supernatant against Multidrug-Resistant Bacteria and Its Potential Use as an Alternative to Antimicrobial Agents. Microorganisms. 2023;11(1):182. doi:10.3390/microorganisms11010182

BibTeX
@article{Lee2023,
  author = {Lee, Hong-Jae and Lee, Joong-Bok and Park, Seung-Yong and Choi, In-Soo and Lee, Sang-Won},
  title = {Antimicrobial Activity of Ligilactobacillus animalis SWLA-1 and Its Cell-Free Supernatant against Multidrug-Resistant Bacteria and Its Potential Use as an Alternative to Antimicrobial Agents},
  journal = {Microorganisms},
  year = {2023},
  volume = {11},
  number = {1},
  pages = {182},
  doi = {10.3390/microorganisms11010182}
}
Kostenlos starten →